Melola Discovery

← Melola Discovery

Open access Jurnal

Antibiotic Susceptibility Pattern in Clinical Isolates of Pseudomonas aeruginosa

Nusantara Medical Science Journal · Vol. ume (2021) · pp. 66–73

DOI
10.20956/nmsj.v6i2.14172
ISSN
2597-7288, 2460-9757
Published
2021-11-17
Publisher
Faculty of Medicine, Hasanuddin University.
Language
en
License
creativecommons.org/licenses/by/4.0

Abstract

Introduction: Pseudomonas aeruginosa is an opportunistic pathogen and causes of nosocomial infections in hospitals. Due to high antibiotic resistance and the ability to develop new resistance during antibiotic treatment, Pseudomonas aeruginosa infection is difficult to eradicate because the physical treatment becomes difficult and ineffective. This study was conducted to evaluate the antibiotic sensitivity pattern of Pseudomonas aeruginosa strains at two different hospital in Makassar. Methods: This study is a cross-sectional study from March to May 2021. The research samples were taken from the results of culture and antibiotic sensitivity tests conducted at two different hospital, Hasanuddin University Hospital and Dr. Wahidin Sudirohusodo Hospital for the period January 1 to September 30, 2019. A total of 84 samples were cultured and tested for antibiotic sensitivity of Pseudomonas aeruginosa. Results: Antibiotic sensitivity of Pseudomonas aeruginosa was best with aminoglycoside antibiotics, gentamicin (100%) at Hasanuddin University Hospital and amikacin (95.8%) at Dr. Wahidin Sudirohusodo Hospital. At Hasanuddin University Hospital followed by antibiotics amikacin (92.3%) and meropenem (84.6%). At Dr. Wahidin Sudirohusodo Hospital, Pseudomonas aeruginosa also showed good sensitivity to gentamicin (91.5%) and meropenem (77.5%). The sensitivity of Pseudomonas aeruginosa was lowest to piperacillin/tazobactam. Conclusions: This study shows that the level of effectiveness of the antibiotics meropenem, amikacin and gentamicin is high enough and it can be used as a treatment option in Pseudomonas aeruginosa infection. This study can help as a reference to prevent mortality and morbidity associated with Pseudomonas aeruginosa infection.

Collaboration network of the authors

33 authors · 108 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Punggawa Gauk KarimAffiliation unknown1
Hafsah KatuAffiliation unknown1
Irfan SugiantoAffiliation unknown1
Andi Abidah RustamAffiliation unknown1
Muh. Nasrum MassiAffiliation unknown1
Andi Nur AsrinawatyAffiliation unknown1
Andi IhwanAffiliation unknown1
Kenny Edward YapAffiliation unknown1
Andi Asadul IslamAffiliation unknown1
Junus Asiu Bulu BaanAffiliation unknown1
Dhian Karina Aprilani HattahAffiliation unknown1
Sriwijaya SriwijayaAffiliation unknown1
Nita MarianaAffiliation unknown1
Erwin ChandraAffiliation unknown1
Sulmiati SulmiatiAffiliation unknown1
Fonny JoshAffiliation unknown1
Sachraswaty RachmanAffiliation unknown1
Nur Indah PurnamasariAffiliation unknown1
Muhammad SabirAffiliation unknown1
SRI WAHYUNIAffiliation unknown1
Burhanuddin BaharAffiliation unknown1
Rosdiana NatzirAffiliation unknown1
Mochammad HattaAffiliation unknown1
Ahyar AhmadAffiliation unknown1
Ade Rifka JunitaAffiliation unknown1
Ressy DwiyantiAffiliation unknown1
Muhammad Reza PrimagunaAffiliation unknown1
Muhammad Nasrum MassiAffiliation unknown1
Rosana AgusAffiliation unknown1
Raymond TumandukAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://journal.unhas.ac.id/index.php/jmednus/oai, first harvested 5 Nov 2026, last seen 5 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Antibiotic Susceptibility Pattern in Clinical Isolates of Pseudomonas aeruginosa</dc:title>
	<dc:creator xml:lang="en">Do Toka, Wahyunita</dc:creator>
	<dc:creator xml:lang="en">Sjahril, Rizalinda</dc:creator>
	<dc:creator xml:lang="en">Hamid, Firdaus</dc:creator>
	<dc:description xml:lang="en">Introduction: Pseudomonas aeruginosa is an opportunistic pathogen and causes of nosocomial infections in hospitals. Due to high antibiotic resistance and the ability to develop new resistance during antibiotic treatment, Pseudomonas aeruginosa infection is difficult to eradicate because the physical treatment becomes difficult and ineffective. This study was conducted to evaluate the antibiotic sensitivity pattern of Pseudomonas aeruginosa strains at two different hospital in Makassar. Methods: This study is a cross-sectional study from March to May 2021. The research samples were taken from the results of culture and antibiotic sensitivity tests conducted at two different hospital, Hasanuddin University Hospital and Dr. Wahidin Sudirohusodo Hospital for the period January 1 to September 30, 2019. A total of 84 samples were cultured and tested for antibiotic sensitivity of Pseudomonas aeruginosa. Results: Antibiotic sensitivity of Pseudomonas aeruginosa was best with aminoglycoside antibiotics, gentamicin (100%) at Hasanuddin University Hospital and amikacin (95.8%) at Dr. Wahidin Sudirohusodo Hospital. At Hasanuddin University Hospital followed by antibiotics amikacin (92.3%) and meropenem (84.6%). At Dr. Wahidin Sudirohusodo Hospital, Pseudomonas aeruginosa also showed good sensitivity to gentamicin (91.5%) and meropenem (77.5%). The sensitivity of Pseudomonas aeruginosa was lowest to piperacillin/tazobactam. Conclusions: &amp;nbsp;This study shows that the level of effectiveness of the antibiotics meropenem, amikacin and gentamicin is high enough and it can be used as a treatment option in Pseudomonas aeruginosa infection. This study can help as a reference to prevent mortality and morbidity associated with Pseudomonas aeruginosa infection.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Hasanuddin University.</dc:publisher>
	<dc:date>2021-11-17</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unhas.ac.id/index.php/jmednus/article/view/14172</dc:identifier>
	<dc:identifier>10.20956/nmsj.v6i2.14172</dc:identifier>
	<dc:source xml:lang="en">Nusantara Medical Science Journal; Volume 6 Issue 2, July - December 2021; 66-73</dc:source>
	<dc:source>2597-7288</dc:source>
	<dc:source>2460-9757</dc:source>
	<dc:source>10.20956/nmsj.v6i2</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://journal.unhas.ac.id/index.php/jmednus/article/view/14172/7500</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2021 Nusantara Medical Science Journal</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>